India Diabetes Market Research Report - Forecast To 2032

India Diabetes Market information, by Type (Type 1, Type 2, and Gestational diabetes), by Test (Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others), by Devices (Blood glucose monitoring devices, Diabetes management devices, and others) by Treatment (Medications, Insulin therapy, Transplantation, Bariatric surgery and others) - Forecast to 2032

ID: MRFR/Pharma/2180-HCR | 60 Pages | Author: Kinjoll Dey | February 2024         

Diabetes Market Speak to Analyst Request a Free Sample

India Diabetes Market Overview


The India diabetes market is expected to earn a market value of USD 11.46 billion by 2032 at a CAGR of 6.5% over the forecast period of 2023-2032. Diabetes is a chronic metabolic condition that results in high blood glucose levels, which seriously harms the heart, blood vessels, eyes, kidneys, and nerves. Drugs used to treat diabetes are known as diabetic therapies, which consist of oral diabetes medications and human insulin mimics.


India Diabetes Market Overview


India Diabetes Market Trends


The leading causes of diabetes mellitus in Indians are obesity, particularly central obesity, increased visceral fat brought on by physical inactivity, and diets high in calories, fat, and sugar. The most prevalent work culture that is still practised in the nation, which involves consuming fast food while engaging in little to no physical exercise and spending hours in one position while seated, is a major factor in the rapid rise in diabetes incidence among India's working-age population. Additionally, the rising number of diabetic people and its growing prevalence and expanding use of insulin-delivery and continuous glucose monitoring devices are propelling market expansion. In India, 77 million people were estimated to have diabetes in 2019, and by 2045, that number is expected to reach over 134 million. About 57% of these people are still undiagnosed. However, problems faced by poor individuals across India in managing diabetes care are major restraining factors for the market.


India Diabetes Market Segment Insights 


The said market segment has been segmented based on type which comprises Type 1, Type 2, and Gestational diabetes.


Based on tests, the market is segmented into Random blood sugar tests, Fasting blood sugar tests, Oral glucose tolerance tests, Initial glucose challenge tests and others.


Based on devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others.


Based on treatment, the market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and Blood Sugar Treatment.


India Diabetes Regional Insights 


Considering the scenario of the Indian diabetes market, the western region is believed to be the largest market share holder for diabetes care. Moreover, the Eastern and Northern regions are also growing and the second-largest market for India's Diabetes treatment sector. On the other hand, the Southern Indian market is expected to grow at a significant rate in the Indian diabetes market during the forecasted period. The central region is likely to have limited but moderate growth in the said market segment.


India Diabetes Market Key Players Insights



  • Novo Nordisk A/S (Denmark)

  • USV Private Limited (India)

  • sanofi-aventis U.S

  • LLC (US)

  • Novartis AG (Switzerland)

  • Merck & Co., Inc. (US)

  • Becton Dickinson and Company (US)

  • Roche Diabetes Care, Inc.(US),

  • Johnson & Johnson Services, Inc.(us)

  • Bayer AG (Germany)

  • Ypsomed (Switzerland)


The report for India Diabetes Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
 

Recent Developments in India Diabetes Market 


February 2024:In February 2024, Roche Diabetes Care Launched a new continuous glucose monitoring (CGM) system in India, aiming to improve diabetes management and glycemic control.


 


Study objectives of India Diabetes Market


  • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Indian Diabetes Market

  • To provide insights about factors affecting the market growth

  • To analyze the India Diabetes Market based on various factors - price analysis, supply chain analysis, Porters Five Forces analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments

  • To provide detailed analysis of the market with respect to the current market size and future prospective

  • To provide detailed analysis of the market for segments by type, by test, by devices, by treatment, and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Market



 Intended Audience




  • Hospitals and Clinics

  • Diabetes drugs and devices manufacturers

  • Diabetes drugs and devices suppliers

  • Government and Independent Regulatory Authorities

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Potential Investors



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 11.46 billion
  CAGR   6.5%
  Base Year   2021
  Forecast Period   2023-2032
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Test, Devices, Treatment
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Novo Nordisk A/S (Denmark), USV Private Limited (India), sanofi-aventis U.S. LLC (US), Novartis AG (Switzerland), Merck & Co., Inc. (US), Becton Dickinson and Company (US), Roche Diabetes Care, Inc.(US),Johnson & Johnson Services, Inc.(us), Bayer AG (Germany), Ypsomed (Switzerland)
  Key Market Opportunities   Research and developments
  Key Market Drivers ·  Increasing number of patients ·  Increasing urbanization ·  Healthcare infrastructure ·  Increasing spending on healthcare




Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players‚Äô financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid